Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Syn-Tech Chem & Pharm CoROCO:1777 +0.41%73 Net Margin % is 28.45% as of Dec. 2025, which is 42% above its 10-year median of 19.98. GuruFocus rates ROCO:1777 with a GF Score™ of 73/100 and a GF Value™ of NT$106.95 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 942 Biotechnology companies, Syn-Tech Chem & Pharm Co ranks better than 87.37% on this metric.
The historical rank and industry rank for Syn-Tech Chem & Pharm Co's Net Margin % or its related term are showing as below:
ROCO:1777'
s Net Margin % Range Over the Past 10 Years
Min: 8.6 Med: 19.98 Max: 31.27
Current: 20.12
ROCO:1777's Net Margin % is ranked better than 87.37% of 942
companies
in the Biotechnology industry
Industry Median: -88.295
vs ROCO:1777: 20.12
Syn-Tech Chem & Pharm Co (ROCO:1777) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Syn-Tech Chem & Pharm Co Net Margin % Related Terms
Syn-Tech Chem & Pharm Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1777 vs VRTX, REGN, ALNY: Net Margin % Comparison
For the Biotechnology subindustry, Syn-Tech Chem & Pharm Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syn-Tech Chem & Pharm Co Net Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Syn-Tech Chem & Pharm Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Syn-Tech Chem & Pharm Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syn-Tech Chem & Pharm Co (ROCO:1777) has a Net Margin % of 28.45% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Syn-Tech Chem & Pharm Co and its competitors. This is 42% above median its historical median of 19.98. Over the past decade, Syn-Tech Chem & Pharm Co's Net Margin % has ranged from 8.60 to 31.27. According to the industry distribution chart, Syn-Tech Chem & Pharm Co ranks #119 out of 942 companies in the Biotechnology industry, placing it in the top 12.6%.
Is Syn-Tech Chem & Pharm Co's Net Margin % too high?
Syn-Tech Chem & Pharm Co's current Net Margin % of 28.45% is 42% above median its 10-year median of 19.98. Over the past 10 years, this metric has ranged from a low of 8.60 to a high of 31.27. Based on the distribution chart, Syn-Tech Chem & Pharm Co ranks #119 out of 942 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Syn-Tech Chem & Pharm Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syn-Tech Chem & Pharm Co's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Syn-Tech Chem & Pharm Co ranks #119 out of 942 companies for Net Margin %. This places Syn-Tech Chem & Pharm Co in the top 13% of its industry — outperforming the majority of peers. Historically, Syn-Tech Chem & Pharm Co's own Net Margin % has ranged from 8.60 to 31.27 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Syn-Tech Chem & Pharm Co and its competitors. Syn-Tech Chem & Pharm Co's current Net Margin % is 28.45%, which is 42% above median its own 10-year median of 19.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syn-Tech Chem & Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, Syn-Tech Chem & Pharm Co (ROCO:1777) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$106.95, compared to a current price of NT$72.80 — trading 31.9% below its estimated fair value. The current Net Margin % is 28.45%, which is 42% above median its 10-year median of 19.98. Syn-Tech Chem & Pharm Co's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Syn-Tech Chem & Pharm Co (ROCO:1777), the current Net Margin % is 28.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Syn-Tech Chem & Pharm Co (ROCO:1777) Overvalued in 2026?
Based on GuruFocus' analysis, Syn-Tech Chem & Pharm Co stock appears to be undervalued.
The current stock price of NT$72.80 is trading 31.9% below its estimated GF Value™ of NT$106.95.
GuruFocus considers Syn-Tech Chem & Pharm Co to be Significantly Undervalued.
Key valuation signals for ROCO:1777:
Net Margin %: 28.45% (42% above median its 10-year median of 19.98)
GF Value™: NT$106.95 vs. price of NT$72.80 (31.9% below fair value)
No single metric tells the full story. See the ROCO:1777 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Syn-Tech Chem & Pharm Co Ltd is engaged in the manufacture and sale of western medicines, veterinary drugs, food additives, cosmetics, and related businesses. It manufactures and sells Active Pharmaceutical Ingredients for domestic and foreign pharmaceutical companies and trade agents. Its products include Alfuzosin HCl, Atomoxetine HCl, Chlorzoxazone, Chlormezanone, Cloperastine HCl, Crotamiton, Diclofenac Epolamine, and others. It generates the majority of its revenue from Asia excluding Taiwan.
73GF Score
Get the complete analysis for ROCO:1777
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1777 has been successfully added to your 
